Approval · Notice of Compliance 1024 · 2000
LARGACTIL: Notice of Compliance 1024
Issued December 19, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1024
- Date
- December 19, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Neuroleptic
Products in this notice
Medicinal ingredients
- CHLORPROMAZINE HCL 40 MG per ML
- CHLORPROMAZINE HCL 25 MG per 5ML
- CHLORPROMAZINE HCL 100 MG per 5ML
- CHLORPROMAZINE 100 MG per SUP
- CHLORPROMAZINE HCL 50 MG per AMP